NanoString Technologies, Inc. provided revenue guidance for the fourth quarter of 2022. The company expects total fourth quarter revenue of $33 million to $35 million.
NanoString Technologies, Inc.
Equities
NSTGQ
US63009R1095
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 USD | +0.08% | +7.20% | -83.30% |
May. 07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
May. 07 | First Amended Reorganization Plan and Disclosure Statement Filed by NanoString Technologies, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.30% | 6.01M | |
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+9.39% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- NSTGQ Stock
- News NanoString Technologies, Inc.
- NanoString Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022